Paragon BioTeck, Inc., Signs Exclusive License Agreement with Bausch + Lomb for Phenylephrine
Recent U.S FDA Approval of Paragon’s NDA Clears the Way for Bausch + Lomb Commercialization TIGARD, Ore. & MADISON, N.J....
RECENT POSTS
- Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition 09/14/2018
- Paragon BioTeck, Inc. Hosts Pearl Buck Preschool Holiday Event 12/01/2017
- Paragon BioTeck, Inc. Announces Call for 2018 Koch Kellan Scholarship Applicants 10/02/2017
- Talking to Patients About Eye Health 08/24/2017
- Xinxin Zhang shares her experience at ASCRS•ASOS 06/12/2017
